These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 23442082)

  • 1. Receptor-based targeting of therapeutics.
    Mehra NK; Mishra V; Jain NK
    Ther Deliv; 2013 Mar; 4(3):369-94. PubMed ID: 23442082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ligand based dendritic systems for tumor targeting.
    Agarwal A; Saraf S; Asthana A; Gupta U; Gajbhiye V; Jain NK
    Int J Pharm; 2008 Feb; 350(1-2):3-13. PubMed ID: 18162345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted nanoparticles for image-guided treatment of triple-negative breast cancer: clinical significance and technological advances.
    Miller-Kleinhenz JM; Bozeman EN; Yang L
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2015; 7(6):797-816. PubMed ID: 25966677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Injectable nanomaterials for drug delivery: carriers, targeting moieties, and therapeutics.
    Webster DM; Sundaram P; Byrne ME
    Eur J Pharm Biopharm; 2013 May; 84(1):1-20. PubMed ID: 23313176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted delivery of doxorubicin using stealth liposomes modified with transferrin.
    Li X; Ding L; Xu Y; Wang Y; Ping Q
    Int J Pharm; 2009 May; 373(1-2):116-23. PubMed ID: 19429296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery and development of folic-acid-based receptor targeting for imaging and therapy of cancer and inflammatory diseases.
    Low PS; Henne WA; Doorneweerd DD
    Acc Chem Res; 2008 Jan; 41(1):120-9. PubMed ID: 17655275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymeric nanomedicines as a promising vehicle for solid tumor therapy and targeting.
    Gupta M; Agrawal GP; Vyas SP
    Curr Mol Med; 2013 Jan; 13(1):179-204. PubMed ID: 22834834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Micro- and nanocarrier-mediated lung targeting.
    Kurmi BD; Kayat J; Gajbhiye V; Tekade RK; Jain NK
    Expert Opin Drug Deliv; 2010 Jul; 7(7):781-94. PubMed ID: 20560777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo biodistribution of prion- and GM1-targeted polymersomes following intravenous administration in mice.
    Stojanov K; Georgieva JV; Brinkhuis RP; van Hest JC; Rutjes FP; Dierckx RA; de Vries EF; Zuhorn IS
    Mol Pharm; 2012 Jun; 9(6):1620-7. PubMed ID: 22536790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HDL-mimicking peptide-lipid nanoparticles with improved tumor targeting.
    Zhang Z; Chen J; Ding L; Jin H; Lovell JF; Corbin IR; Cao W; Lo PC; Yang M; Tsao MS; Luo Q; Zheng G
    Small; 2010 Feb; 6(3):430-7. PubMed ID: 19957284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of ligand-based targeting for the EGF system in cancer.
    Yotsumoto F; Sanui A; Fukami T; Shirota K; Horiuchi S; Tsujioka H; Yoshizato T; Kuroki M; Miyamoto S
    Anticancer Res; 2009 Nov; 29(11):4879-85. PubMed ID: 20032451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of peptide and folate receptor targeting of cancer cells: from single agent to nanoparticle.
    Franzen S
    Expert Opin Drug Deliv; 2011 Mar; 8(3):281-98. PubMed ID: 21306284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemical modification of therapeutic drugs or drug vector systems to achieve targeted therapy: looking for the grail.
    Juillerat-Jeanneret L; Schmitt F
    Med Res Rev; 2007 Jul; 27(4):574-90. PubMed ID: 17022028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The significance of transferrin receptors in oncology: the development of functional nano-based drug delivery systems.
    Tortorella S; Karagiannis TC
    Curr Drug Deliv; 2014; 11(4):427-43. PubMed ID: 24387131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of therapeutic challenges and achievements of methotrexate delivery systems for treatment of cancer and rheumatoid arthritis.
    Abolmaali SS; Tamaddon AM; Dinarvand R
    Cancer Chemother Pharmacol; 2013 May; 71(5):1115-30. PubMed ID: 23292116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanoparticles for drug delivery in cancer treatment.
    Haley B; Frenkel E
    Urol Oncol; 2008; 26(1):57-64. PubMed ID: 18190833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved therapeutic activity of folate-targeted liposomal doxorubicin in folate receptor-expressing tumor models.
    Gabizon A; Tzemach D; Gorin J; Mak L; Amitay Y; Shmeeda H; Zalipsky S
    Cancer Chemother Pharmacol; 2010 May; 66(1):43-52. PubMed ID: 19779718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted anticancer therapy: overexpressed receptors and nanotechnology.
    Akhtar MJ; Ahamed M; Alhadlaq HA; Alrokayan SA; Kumar S
    Clin Chim Acta; 2014 Sep; 436():78-92. PubMed ID: 24836529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved drug delivery to cancer cells: a method using magnetoliposomes that target epidermal growth factor receptors.
    Kullberg M; Mann K; Owens JL
    Med Hypotheses; 2005; 64(3):468-70. PubMed ID: 15617850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted delivery across the blood-brain barrier.
    Gaillard PJ; Visser CC; de Boer AG
    Expert Opin Drug Deliv; 2005 Mar; 2(2):299-309. PubMed ID: 16296755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.